Standout Papers

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine 2022 2026 2023 2024173
  1. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine (2022)
    Hiromi Muramatsu, Kieu Lam et al. Molecular Therapy

Immediate Impact

2 by Nobel laureates 58 standout
Sub-graph 1 of 22

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
3 intermediate papers

Works of Csaba Bajusz being referenced

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
2022
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
2022
and 1 more

Author Peers

Author Last Decade Papers Cites
Csaba Bajusz 269 64 116 76 12 415
Mingmei Cao 175 43 148 101 21 447
G A Cates 259 75 101 145 16 459
Anna Maria Niewiadomska 251 30 95 113 9 462
Heiko Slanina 183 26 120 83 21 473
Efraín E. Rivera-Serrano 185 30 149 68 13 402
Thomas G. Flower 213 68 161 77 8 406
Jonathan J. Knowlton 304 34 151 55 12 486
Dawn Su-Yin Yeo 236 25 94 169 15 476
Michelle A. Loprieno 169 21 160 91 15 406
Stanford Schor 210 52 160 120 11 508

All Works

Loading papers...

Rankless by CCL
2026